Venison is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Venison.
Product ID | 49288-0592_ab729e90-03ec-4b3a-8c11-390b49ff5173 |
NDC | 49288-0592 |
Product Type | Human Prescription Drug |
Proprietary Name | Venison |
Generic Name | Venison |
Dosage Form | Injection, Solution |
Route of Administration | INTRADERMAL; SUBCUTANEOUS |
Marketing Start Date | 1974-03-23 |
Marketing Category | BLA / BLA |
Application Number | BLA102223 |
Labeler Name | Antigen Laboratories, Inc. |
Substance Name | VENISON |
Active Ingredient Strength | 0 g/mL |
Pharm Classes | Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Meat Proteins [EXT] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 1974-03-23 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1974-03-23 |
Inactivation Date | 2019-10-21 |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1974-03-23 |
Inactivation Date | 2019-10-21 |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1974-03-23 |
Inactivation Date | 2019-10-21 |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1974-03-23 |
Inactivation Date | 2019-10-21 |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1974-03-23 |
Inactivation Date | 2019-10-21 |
Ingredient | Strength |
---|---|
VENISON | .05 g/mL |
SPL SET ID: | 422e7c71-ab7d-4064-97b9-a2d0527f18b0 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |